Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,173.00    -4.00 (-0.34%)
Bid:
1,179.00
Ask:
1,180.00
Spread: 1.00 (0.085%)
Market Cap: £813.45m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Exercise of Options and Total Voting Rights

14 Dec 2018 07:00

RNS Number : 4592K
CVS Group plc
14 December 2018
 

14 December 2018

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

 

CVS, one of the UK's leading providers of integrated veterinary services, announces that 19,475 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "New Shares") were issued on 12 December as a result of the exercise of options at 0.2 pence per share by a former employee under the CVS Group Long Term Incentive Plan [2016/2018].

 

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 19 December 2018.

 

Following issue of the New Shares, the Company's total issued share capital will consist of 70,538,506 Ordinary Shares each carrying one voting right. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 70,538,506. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Richard Fairman, Finance Director

 

 

Tel: 01379 644 288

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell / Jen Boorer / Ben Farrow

Rachel Hayes

Tel: 020 7496 3000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDGBDDGXBBGIX
Date   Source Headline
30th Jun 20264:21 pmRNSStandard form for notification of major holdings
30th Jun 202610:59 amRNSStandard form for notification of major holdings
30th Jun 20267:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20269:48 amRNSStandard form for notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.